Back to Journals » Drug Design, Development and Therapy » Volume 13

Quizartinib (AC220): a promising option for acute myeloid leukemia

Total article views   HTML views PDF downloads Totals
7,063 Dovepress* 5,684+ 1,584 7,268
PubMed Central* 1,379 405 1,784
Totals 7,063 1,989 9,052
*Since 8 April 2019

View citations on PubMed Central and Google Scholar